Propranolol improves cognitive function and glymphatic system recovery through STAT3/MMP2 pathway after TBI

There is no effective treatment for cognitive impairment after traumatic brain injury (TBI). Previous studies have demonstrated that propranolol may improve cognitive function. The glymphatic system plays a crucial role in cognitive impairment after TBI. Thus, we explored the mechanism by which propranolol improves cognitive function and promotes glymphatic system recovery after TBI. In vivo, rats were subjected to controlled cortical impact (CCI) and treated with saline, propranolol, S31-201 (an inhibitor of STAT3) and SB-3CT (an inhibitor of MMP2) respectively. Rats then underwent a battery of cognitive tests. We also assessed white matter (WM) integrity and glymphatic system function. The expression of phosphorylated tau (p-tau), amyloid-β (Aβ), aquaporin 4 (AQP4), signal transducer and activator of transcription 3 (STAT3), phosphorylated STAT3 (p-STAT3), and matrix metalloproteinase-2 (MMP2) was evaluated by immunocytochemistry and Western blot. In vitro, the levels of STAT3, p-STAT3, MMP2 and AQP4 were assessed after astrocytes were treated with propranolol, noradrenaline, S31-201 and SB-3CT respectively. In vivo results showed that propranolol, S31-201 and SB-3CT improved cognitive function and restored glymphatic system function after TBI. The deposition of p-tau and Aβ was decreased, and WM integrity was restored in TBI rats treated with propranolol, S31-201 and SB-3CT. Propranolol, S31-201 and SB-3CT induced the overexpression of AQP4 in blood vessels and astrocytes after TBI. In addition, the levels of p-STAT3 and MMP2 were knocked down in propranolol-treated TBI rats. In vitro, propranolol reversed the upregulated expression of p-STAT3 and MMP2 in noradrenaline-treated astrocytes. The noradrenaline-induced impairment of AQP4 expression in astrocytes was antagonized by propranolol, S31-201 and SB-3CT. In conclusion, propranolol may improve cognitive function and facilitate glymphatic system functional recovery after TBI through the STAT3/MMP2 pathway.

Authors

Institutions

Publication Details

Journal
PLoS ONE
Published
2026-08-21
DOI
https://doi.org/10.1371/journal.pone.0353852
Primary Topic
Cerebrospinal fluid and hydrocephalus
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Propranolol improves cognitive function and glymphatic system recovery through STAT3/MMP2 pathway after TBI

Peng Yu, Guohui Huang, Dongming Gao, Lei Li
PLoS ONE
Cerebrospinal fluid and hydrocephalus
article

Propranolol improves cognitive function and glymphatic system recovery through STAT3/MMP2 pathway after TBI

Peng Yu, Guohui Huang, Dongming Gao, Lei Li
article en

Abstract

There is no effective treatment for cognitive impairment after traumatic brain injury (TBI). Previous studies have demonstrated that propranolol may improve cognitive function. The glymphatic system plays a crucial role in cognitive impairment after TBI. Thus, we explored the mechanism by which propranolol improves cognitive function and promotes glymphatic system recovery after TBI. In vivo, rats were subjected to controlled cortical impact (CCI) and treated with saline, propranolol, S31-201 (an inhibitor of STAT3) and SB-3CT (an inhibitor of MMP2) respectively. Rats then underwent a battery of cognitive tests. We also assessed white matter (WM) integrity and glymphatic system function. The expression of phosphorylated tau (p-tau), amyloid-β (Aβ), aquaporin 4 (AQP4), signal transducer and activator of transcription 3 (STAT3), phosphorylated STAT3 (p-STAT3), and matrix metalloproteinase-2 (MMP2) was evaluated by immunocytochemistry and Western blot. In vitro, the levels of STAT3, p-STAT3, MMP2 and AQP4 were assessed after astrocytes were treated with propranolol, noradrenaline, S31-201 and SB-3CT respectively. In vivo results showed that propranolol, S31-201 and SB-3CT improved cognitive function and restored glymphatic system function after TBI. The deposition of p-tau and Aβ was decreased, and WM integrity was restored in TBI rats treated with propranolol, S31-201 and SB-3CT. Propranolol, S31-201 and SB-3CT induced the overexpression of AQP4 in blood vessels and astrocytes after TBI. In addition, the levels of p-STAT3 and MMP2 were knocked down in propranolol-treated TBI rats. In vitro, propranolol reversed the upregulated expression of p-STAT3 and MMP2 in noradrenaline-treated astrocytes. The noradrenaline-induced impairment of AQP4 expression in astrocytes was antagonized by propranolol, S31-201 and SB-3CT. In conclusion, propranolol may improve cognitive function and facilitate glymphatic system functional recovery after TBI through the STAT3/MMP2 pathway.

PLoS ONEVol. 21(8)
Tongji University (CN), Fudan University (CN), Huadong Hospital (CN), Shanghai Tenth People's Hospital (CN)
National Natural Science Foundation of China
Good health and well-being
Openalex Percentile: Top 15%
Cerebrospinal fluid and hydrocephalus
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.